Resverlogix Announces Publication in High-impact, Peer-reviewed Journal, Clinical Epigenetics
|
4
|
Resverlogix Corp.
|
Nov 12, 2020 09:46AM
|
Re: Why is agora deleting posts?? Was that last one to honest???
|
|
Zenith Epigenetics
|
Nov 11, 2020 04:49PM
|
Re: AHA Abstracts will be posted Monday 11/9 at 4AM CST
|
7
|
Resverlogix Corp.
|
Nov 09, 2020 10:55AM
|
Re: Hmmmm Covid News...
|
2
|
Resverlogix Corp.
|
Nov 09, 2020 10:45AM
|
AHA Abstracts will be posted Monday 11/9 at 4AM CST
|
6
|
Resverlogix Corp.
|
Nov 08, 2020 12:31PM
|
Re: Election Day
|
5
|
Resverlogix Corp.
|
Nov 05, 2020 10:09PM
|
Re: Bioasis Announces Sale of Royalty Interest in LSD Enzymes Being Developed Under the Chiesi Group–Bioasis Strategic Alliance to XOMA Corporation
|
2
|
BIOASIS TECHNOLOGIES INC
|
Nov 04, 2020 05:33PM
|
Bioasis Announces Sale of Royalty Interest in LSD Enzymes Being Developed Under the Chiesi Group–Bioasis Strategic Alliance to XOMA Corporation
|
2
|
BIOASIS TECHNOLOGIES INC
|
Nov 04, 2020 05:32PM
|
Re: Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers
|
9
|
Resverlogix Corp.
|
Nov 02, 2020 07:56AM
|
Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers
|
6
|
Resverlogix Corp.
|
Nov 02, 2020 07:46AM
|
Zenith Confirms Interim Filings on SEDAR
|
2
|
Zenith Epigenetics
|
Oct 28, 2020 10:34AM
|
Re: Presentation
|
9
|
Resverlogix Corp.
|
Oct 26, 2020 01:37PM
|
Re: Presentation
|
1
|
Resverlogix Corp.
|
Oct 26, 2020 11:48AM
|
A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-19 Effectiveness Including Reducing Cytokine Storms
|
8
|
Resverlogix Corp.
|
Oct 26, 2020 08:15AM
|
Re: Article
|
5
|
Resverlogix Corp.
|
Oct 25, 2020 06:20PM
|
Re: Presentation slides are up
|
4
|
Resverlogix Corp.
|
Oct 25, 2020 06:17PM
|
Re: Article
|
4
|
Resverlogix Corp.
|
Oct 25, 2020 12:45PM
|
Re: Presentation
|
6
|
Resverlogix Corp.
|
Oct 24, 2020 12:12PM
|
Re: Presentation
|
4
|
Resverlogix Corp.
|
Oct 23, 2020 02:40PM
|
Re: Presentation
|
3
|
Resverlogix Corp.
|
Oct 23, 2020 10:03AM
|